慢性病和衰老:解剖p53/p21通路作为治疗点
Kavita Goyal1, Muhammad Afzal2, Abdulmalik Saleh Alfawaz Altamimi3
1Department of Biotechnology, Graphic Era (Deemed to Be University), Clement Town, Dehradun, 248002, India.
Biogerontology
|December 26, 2024
概括
衰老的脏表现出细胞衰老的增加,由p53/p21通路驱动. 这种衰老会损害功能和恢复,加速慢性病的进展.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年学是指老年学的学科.
- 分子生物学分子生物学
背景情况:
- 衰老的经历结构和功能变化,包括降低再生和增加纤维化.
- 细胞衰老,细胞亡和细胞循环失调是衰老的标志.
- 该p53/p21通路是与年龄相关的脏变化的核心.
研究的目的:
- 审查p53/p21通路在衰老和细胞衰老中的作用.
- 探索细胞衰老如何影响功能和受伤恢复.
- 讨论针对慢性病 (CKD) 中的p53/p21途径的新兴治疗策略.
主要方法:
- 对脏衰老,细胞衰老和p53/p21通路研究的文献综述.
- 对将p53/p21信号与衰老联系起来的分子机制的分析.
- 在CKD的背景下检查针对衰老的治疗干预措施.
主要成果:
- 持续激活p53/p21通路导致老化脏中的细胞衰老.
- 累积的衰老细胞破坏了脏的微环境,损害了功能.
- 衰老加剧了损伤的易受性,并阻碍了恢复,加速了CKD的进展.
结论:
- p53/p21通路是衰老脏细胞衰老的关键调解者.
- 准这种途径为管理与年龄相关的CKD提供了潜在的治疗途径.
- 旨在缓解衰老的干预措施可能会改善老年人群中的脏健康.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K


